| These highlights do not include all the information needed to use ACTHAR ® GEL safely and effectively. See full prescribing information for ACTHAR GEL. ACTHAR GEL (repository corticotropin injection), for intramuscular or subcutaneous use Initial U.S. Approval: 1952 | Product name | Keenova ARD LLC | 2026-10-13 |
| BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), for oral use Initial U.S. Approval: 1985 | Product name | Granules Pharmaceuticals Inc. | 2026-10-08 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | ScieGen Pharmaceuticals, Inc. | 2026-10-08 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | BluePoint Laboratories | Intas Pharmaceuticals Ltd | 2026-10-07 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Aphena Pharma Solutions - Tennessee, LLC | 2026-09-29 |
| ACETAMINOPHEN INJECTION 1,000mg PER 100mL (10mg/mL) | Product name | HF Acquisition Co LLC, DBA HealthFirst | 2026-09-24 |
| Bupropion HCL ER (XL) | Product name | Direct_Rx | 2026-09-22 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release (SR) tablets for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-09-17 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | American Health Packaging | 2026-08-31 |
| These highlights do not include all the information needed to use ACETAMINOPHEN INJECTION safely and effectively. See full prescribing information for ACETAMINOPHEN INJECTION. ACETAMINOPHEN injection, for intravenous use Initial U.S. Approval: 1951 | Product name | REMEDYREPACK INC. | 2026-08-28 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-08-27 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-08-26 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Aphena Pharma Solutions - Tennessee, LLC | 2026-08-25 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Quallent Pharmaceuticals Health LLC | LUPIN LIMITED | 2026-08-25 |
| TrophAmine ® (Amino Acid Injection) | Product name | B. Braun Medical Inc. | 2026-08-19 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 <span style="font-weight : bold;" data-mce-style="font-weight: bold;">These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. <br><br>AUVELI | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2026-08-17 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release (SR) tablets for oral use Initial U.S. Approval: 1985 | Product name | Cardinal Health 107, LLC | 2026-08-12 |
| Hepatic-Tone | Product name | Energetix Corporation | 2026-08-11 |
| Metal-Chord | Product name | Energetix Corporation | 2026-08-11 |
| DRUG FACTS: | Product name | Energique, Inc. | Apotheca Company | 2026-07-31 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2026-07-30 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-07-24 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Major Pharmaceuticals | 2026-07-23 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-07-20 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-07-16 |
| These highlights do not include all the information needed to use ACTHAR ® GEL safely and effectively. See full prescribing information for ACTHAR GEL. ACTHAR GEL (repository corticotropin injection), for intramuscular or subcutaneous use Initial U.S. Approval: 1952 | Product name | Mallinckrodt ARD LLC | 2026-07-15 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | A-S Medication Solutions | 2026-07-14 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | A-S Medication Solutions | 2026-07-14 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2026-07-14 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-06-22 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Northwind Health Company, LLC | 2026-06-19 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-06-12 |
| These highlights do not include all the information needed to use VANRAFIA safely and effectively. See full prescribing information for VANRAFIA. VANRAFIA ™ (atrasentan) tablets, for oral use Initial U.S. Approval: 2025 | Product name | Novartis Pharmaceuticals Corporation | 2026-06-12 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-06-11 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-06-10 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release (SR) tablets for oral use Initial U.S. Approval: 1985 | Product name | Major Pharmaceuticals | 2026-06-08 |
| DRUG FACTS: | Product name | Deseret Biologicals, Inc. | Apotheca Company | 2026-06-02 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2026-06-01 |
| These highlights do not include all the information needed to use EDARAVONE INJECTION safely and effectively. See full prescribing information for EDARAVONE INJECTION. EDARAVONE injection, for intravenous use Initial U.S. Approval: 2017 | Product name | XGen Pharmaceuticals DJB, Inc. | 2026-05-28 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-05-22 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-05-15 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-05-14 |
| DRUG FACTS: | Product name | Deseret Biologicals, Inc. | Apotheca Company | 2026-05-06 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2026-05-06 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2026-05-06 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Coupler LLC | LUPIN LIMITED | 2026-05-06 |
| These highlights do not include all the information needed to use RADICAVA or RADICAVA ORS safely and effectively. See full prescribing information for RADICAVA or RADICAVA ORS. RADICAVA ® (edaravone) injection, for intravenous use RADICAVA ORS ® (edaravone) oral suspension Initial U.S. Approval: 2017 | Product name | Shionogi Inc. | 2026-05-05 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-05-01 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-04-30 |
| DRUG FACTS: | Product name | BioActive Nutritional, Inc. | Apotheca Company | 2026-04-27 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Quallent Pharmaceuticals Health LLC | LUPIN LIMITED | 2026-04-24 |
| These highlights do not include all the information needed to use ACETAMINOPHEN INJECTION safely and effectively. See full prescribing information for ACETAMINOPHEN INJECTION. ACETAMINOPHEN Injection Initial U.S. Approval: 1951 | Product name | Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited | 2026-04-23 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2026-04-22 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Epic Pharma, LLC | Yichang Humanwell Pharmaceutical Co., Ltd. | Yichang Humanwell Oral Solid Dosage Plant | 2026-04-21 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-04-16 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release tablets USP (SR) for oral use Initial U.S. Approval: 1985 | Product name | Cardinal Health 107, LLC | 2026-04-15 |
| These highlights do not include all the information needed to use ELCYS ® safely and effectively. See full prescribing information for ELCYS ® . ELCYS ® (cysteine hydrochloride injection), for intravenous use Initial U.S. Approval: 1971 | Product name | Exela Pharma Sciences, LLC | 2026-04-09 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-04-08 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Quallent Pharmaceuticals Health LLC | LUPIN LIMITED | 2026-04-06 |
| These highlights do not include all the information needed to use RADICAVA or RADICAVA ORS safely and effectively. See full prescribing information for RADICAVA or RADICAVA ORS . RADICAVA® (edaravone) injection, for intravenous use RADICAVA ORS® (edaravone) oral suspension Initial U.S. Approval: 2017 | Product name | Shionogi Inc. | 2026-04-02 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-04-01 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release (SR) tablets for oral use Initial U.S. Approval: 1985 | Product name | Solco Healthcare US LLC | 2026-03-31 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Bryant Ranch Prepack | 2026-03-31 |
| These highlights do not include all the information needed to use ZEVASKYN ® safely and effectively. See full prescribing information for ZEVASKYN . ZEVASKYN ( prademagene zamikeracel ) , gene - modified cellular sheet s , for topical use Initial U.S. Approval: 20 25 | Product name | Abeona Therapeutics Inc. | 2026-03-31 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-03-24 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Preferred Pharmaceuticals, Inc. | 2026-03-23 |
| These highlights do not include all the information needed to use ACETAMINOPHEN INJECTION safely and effectively. See full prescribing information for ACETAMINOPHEN INJECTION . ACETAMINOPHEN injection, for intravenous infusion Initial U.S. Approval: 1951 | Product name | Mylan Institutional LLC | 2026-03-20 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release tablets USP (SR) for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-03-20 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Preferred Pharmaceuticals, Inc. | 2026-03-20 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Preferred Pharmaceuticals, Inc. | 2026-03-20 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | Preferred Pharmaceuticals Inc. | 2026-03-20 |
| These highlights do not include all the information needed to use ZEVASKYN ® safely and effectively. See full prescribing information for ZEVASKYN . ZEVASKYN ( prademagene zamikeracel ) , gene - modified cellular sheet s , for topical use Initial U.S. Approval: 20 25 | Product name | Abeona Therapeutics Inc. | 2026-03-19 |
| DRUG FACTS: | Product name | Pick Enterprises Corp | Apotheca Company | 2026-03-13 |
| DRUG FACTS: | Product name | Carbalor LLC | Apotheca Company | 2026-03-12 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-03-09 |
| Bupropion HCL ER (XL) | Product name | Direct_Rx | 2026-03-05 |
| These highlights do not include all the information needed to use bupropion hydrochloride extended-release tablets (SR) safely and effectively. See full prescribing information for bupropion hydrochloride extended-release tablets (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Epic Pharma, LLC | Yichang Humanwell Pharmaceutical Co,. Ltd. | Yichang Humanwell Oral Solid Dosge Plant | 2026-02-28 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Epic Pharma, LLC | Yichang Humanwell Pharmaceutical Co., Ltd. | Yichang Humanwell Oral Solid Dosage Plant | 2026-02-28 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | Epic Pharma, LLC | Yichang Humanwell Pharmaceutical Co., Ltd. | Yichang Humanwell Oral Solid Dosage Plant | 2026-02-28 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Aphena Pharma Solutions - Tennessee, LLC | 2026-02-27 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-02-25 |
| DRUG FACTS: | Product name | Energique, Inc. | Apotheca Company | 2026-02-18 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-02-16 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Dr. Reddy’s Laboratories Inc. | ScieGen Pharmaceuticals, Inc. | 2026-02-12 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-02-11 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2026-02-06 |
| Serious Skincare Serious-C3 Plasma Bio Technology C Cream SPF 30 | Product name | Flageoli Limited | SOCIETA' ITALIANA PROGETTI RICERCHE E SVILUPPO SRL | 2026-02-04 |
| These highlights do not include all the information needed to use ACETAMINOPHEN injection for intravenous use safely and effectively. See full prescribing information for ACETAMINOPHEN injection for intravenous use. ACETAMINOPHEN Injection for intravenous use Initial U.S. Approval: 1951 | Product name | Hikma Pharmaceuticals USA Inc. | 2026-02-03 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release tablets USP (SR) for oral use Initial U.S. Approval: 1985 | Product name | Major Pharmaceuticals | 2026-01-21 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | ScieGen Pharmaceuticals, Inc. | 2026-01-19 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Radha Pharmaceuticals, Inc. | ScieGen Pharmaceuticals, Inc. | 2026-01-19 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Northwind Health Company, LLC | 2026-01-19 |
| These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 2023 | Product name | CellTrans Inc. | 2026-01-13 |
| Drug Facts: | Product name | H2 Nutrition | Apotheca Company | 2026-01-12 |
| DRUG FACTS: | Product name | Murphree Chiropractic | Apotheca Company | 2026-01-12 |
| Drug Facts: | Product name | Healthy Habits Management Company Inc. | Apotheca Company | 2026-01-12 |
| DRUG FACTS: | Product name | InLight Creation, LLC. | Apotheca Company | 2026-01-09 |
| HHD | Product name | Professional Complementary Health Formulas | Natural Pharmaceutical Manufacturing LLC | 2026-01-08 |
| LCYS | Product name | Professional Complementary Health Formulas | Natural Pharmaceutical Manufacturing LLC | 2026-01-08 |
| R306 | Product name | Professional Complementary Health Formulas | Natural Pharmaceutical Manufacturing LLC | 2026-01-08 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE (SR) TABLETS. BUPROPION hydrochloride extended-release tablets USP (SR) for oral use Initial U.S. Approval: 1985 | Product name | Northwind Health Company, LLC | 2026-01-01 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985 | Product name | Northwind Health Company, LLC | 2026-01-01 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Northwind Health Company, LLC | 2026-01-01 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2025-12-31 |
| These highlights do not include all the information needed to use TAUVID safely and effectively. See full prescribing information for TAUVID. TAUVID™ (flortaucipir F 18 injection), for intravenous use Initial U.S. Approval: 2020 | Product name | Eli Lilly and Company | 2025-12-30 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2025-12-29 |
| These highlights do not include all the information needed to use RADICAVA or RADICAVA ORS safely and effectively. See full prescribing information for RADICAVA or RADICAVA ORS . RADICAVA® (edaravone) injection, for intravenous use RADICAVA ORS® (edaravone) oral suspension Initial U.S. Approval: 2017 | Product name | Tanabe Pharma America, Inc. | 2025-12-19 |
| These highlights do not include all the information needed to use ACETAMINOPHEN INJECTION safely and effectively. See full prescribing information for ACETAMINOPHEN INJECTION. ACETAMINOPHEN injection, for intravenous infusion Initial U.S. Approval: 1951 | Product name | Caplin Steriles Limited | 2025-12-18 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2025-12-15 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | NuCare Pharmaceuticals, Inc. | 2025-12-09 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | NuCare Pharmaceuticals,Inc. | 2025-12-08 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Major Pharmaceuticals | 2025-12-08 |
| These highlights do not include all the information needed to use ACTHAR ® GEL safely and effectively. See full prescribing information for ACTHAR GEL. ACTHAR GEL (repository corticotropin injection), for intramuscular or subcutaneous use Initial U.S. Approval: 1952 | Product name | Mallinckrodt ARD LLC | 2025-12-05 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS, safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS. BUPROPION hydrochloride extended-release tablets, for oral use Initial U.S. Approval: 1985 | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2025-11-25 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2025-11-24 |
| These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985 | Product name | REMEDYREPACK INC. | 2025-11-20 |
| These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY ® (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022 | Product name | Axsome Therapeutics, Inc. | Patheon (part of Thermo Fisher Scientific) | Divi's Laboratories Limited | Dipharma Francis S.r.l. | 2025-11-19 |
| BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), for oral use Initial U.S. Approval: 1985 | Product name | Granules Pharmaceuticals Inc. | 2025-11-13 |
| These highlights do not include all the information needed to use CONTRAVE ® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014 | Product name | Nalpropion Pharmaceuticals LLC | 2025-11-10 |
| These highlights do not include all the information needed to use ACTHAR ® GEL safely and effectively. See full prescribing information for ACTHAR GEL. ACTHAR GEL (repository corticotropin injection), for intramuscular or subcutaneous use Initial U.S. Approval: 1952 | Product name | Mallinckrodt ARD LLC | 2025-11-07 |